ICU MEDICAL INC/DE
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.4B | $2.3B | $2.3B | $1.3B |
| Gross profit | $822.0M | $824.8M | $739.9M | $697.8M | $491.5M |
| Operating income | $42.8M | $43.0M | $22.8M | -$42.9M | $123.2M |
| Operating expenses | $779.2M | $781.8M | $717.0M | $740.7M | $368.2M |
| Cost of revenue | $1.4B | $1.6B | $1.5B | $1.6B | $824.8M |
| Cash from operations | $179.8M | $204.0M | $166.2M | -$62.1M | $267.5M |
| Capital expenditure | $88.0M | $79.4M | $83.9M | $90.3M | $68.5M |
| Free cash flow | $91.8M | $124.7M | $82.3M | -$152.4M | $199.0M |
| Share repurchases | $8.8M | $12.0M | $9.3M | $10.9M | $8.3M |
| Total assets | $4.1B | $4.2B | $4.4B | $4.5B | $1.9B |
| Total debt | $1.3B | $1.6B | $1.6B | $1.7B | — |
Shares outstanding 25.0M · Free float 81.3%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.